Your session is about to expire
← Back to Search
ICARE Treatment for Traumatic Brain Injury (ICARE Trial)
N/A
Recruiting
Led By Flora Hammond, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-test 1), week 7, week 14, week 26, week 38
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a remote rehab program called ICARE to help people with brain injuries and their caregivers improve emotional understanding and relationships. It aims to teach them how to better recognize and respond to emotions, enhancing their relationship quality and emotional well-being.
Who is the study for?
This trial is for U.S. residents over 18 years old who are at least one year post-traumatic brain injury (TBI) and have difficulties with emotion recognition or empathy that they believe started after TBI. Participants must speak English, be able to follow directions, and have a care partner willing to join the study. They need internet access for video calls but can't be from California or have other neurological conditions affecting emotions.
What is being tested?
The ICARE Treatment program is being tested in this trial. It's a TeleRehab intervention designed to help people with TBI improve their ability to recognize and respond to others' emotions using video conferencing technology alongside their care partners.
What are the potential side effects?
Since ICARE Treatment involves therapy sessions rather than medication, typical drug side effects aren't expected. However, participants may experience emotional discomfort or fatigue during the exercises aimed at improving affect recognition and empathy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (pre-test 1), week 7, week 14, week 26, week 38
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-test 1), week 7, week 14, week 26, week 38
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in St. Andrew's Swansea Neurobehavioral Outcome Scale-Interpersonal Behavior (SASNOS-IB)
Secondary study objectives
Change in Advanced Clinical Solutions- Social Perception- Facial Affect Naming subscale (ACS-SP-FAN)
Change in Brock Adaptive Functioning Questionnaire, empathy subscale (BAFQ-E)
Change in Daily Empathic Behavior Survey (DEBS)
+10 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Treatment (ICARE)Experimental Treatment1 Intervention
ICARE treatment consisting of 12 sessions that train affect recognition and empathic behaviors.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Traumatic Brain Injury (TBI) include cognitive-behavioral therapy (CBT), physical therapy, and remote rehabilitation programs like TeleRehab (ICARE). These treatments work by targeting different aspects of brain function and recovery.
CBT helps patients by restructuring negative thought patterns and improving emotional regulation, which is crucial for managing the psychological impact of TBI. Physical therapy focuses on restoring motor function and coordination through repetitive exercises that promote neuroplasticity.
Remote rehabilitation programs, such as TeleRehab, leverage technology to provide consistent, accessible therapy aimed at improving cognitive functions like emotional recognition and response. These mechanisms are vital for TBI patients as they address both the physical and emotional challenges of recovery, ultimately enhancing their quality of life and functional independence.
The effectiveness of traumatic brain injury rehabilitation: a review.Delivering group treatment via videoconference to individuals with traumatic brain injury: a feasibility study.
The effectiveness of traumatic brain injury rehabilitation: a review.Delivering group treatment via videoconference to individuals with traumatic brain injury: a feasibility study.
Find a Location
Who is running the clinical trial?
Indiana UniversityLead Sponsor
1,040 Previous Clinical Trials
1,219,984 Total Patients Enrolled
Flora Hammond, MDPrincipal InvestigatorIndiana University
5 Previous Clinical Trials
329 Total Patients Enrolled
Dawn Neumann, Ph.D.Principal InvestigatorIndiana University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My medications affecting mood will remain stable during the study.I haven't started any new psychotherapy or family/couples therapy in the last 3 months.I have TBI and no other neurological conditions affecting my emotions.My caregiver is someone close who sees me about 3 times a week and can judge my social behaviors.Neither I nor my care partner have issues with sight, hearing, or speaking that would stop us from participating.Neither I nor my care partner have developmental, neurodegenerative, or major psychiatric disorders.I am 18 years old or older.It has been over a year since my traumatic brain injury.My partner and I are not considering separation or divorce.I have had a traumatic brain injury, ranging from mild to severe.I had a TBI at least a year ago, have issues recognizing emotions, and have a care-partner.I and my care partner speak English, can follow directions, and have a computer or tablet with internet for video calls.I am over 18, live in the U.S. but not in California, speak English well, and have a computer or tablet with internet for video calls.I am close to someone with TBI and interact with them often enough to notice changes in their behavior.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment (ICARE)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger